Cook Pharmica (Bloomington, Indiana), the contract biopharmaceutical manufacturing division of Cook Medical, will be expanding capabilities to include formulation, filling and finishing. With the addition of this capability, Cook Pharmica, currently aimed at developing and manufacturing cell culture-based products, will be a centralized source for biotech and pharmaceutical clients' needs from cell line development through parenteral finished packaging.

Cook Pharmica intends to expand its contract manufacturing to include aseptically-filled parenteral vials and syringes for products such as simple solutions and diluents, suspensions, vaccines, proteins and biologics. The expansion will support two filling lines and complementary finishing lines. The design includes one high-speed syringe filling line and one low to medium-speed vial filling line with lyophilization capacity up to 250 square feet.